Armo proposes $86.3M IPO

Immuno-oncology company Armo BioSciences Inc. (Redwood City, Calif.) proposed on Dec. 29, 2017, to raise $86.3 million in an IPO on NASDAQ underwritten by Jefferies, Leerink Partners, BMO Capital Mar...